SCHEMBL31079780

SCHEMBL31079780

NCCc1c[nH]c2cc3c(cc12)OCO3

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 11/20 0.66
HTR1D P28221 9/20 0.66
HTR1A P08908 7/20 0.66
HTR2C P28335 6/20 0.66
HTR1B P28222 6/20 0.66
HTR7 P34969 4/20 0.66
HTR6 P50406 4/20 0.66
HTR2B P41595 3/20 0.66
HTR4 Q13639 3/20 0.66
HTR3E A5X5Y0 2/20 0.66
HTR3B O95264 2/20 0.66
HTR1E P28566 2/20 0.66
HTR1F P30939 2/20 0.66
HTR3A P46098 2/20 0.66
HTR5A P47898 2/20 0.66
HTR3D Q70Z44 2/20 0.66
HTR3C Q8WXA8 2/20 0.66
MAPT P10636 3/20 0.52
NPSR1 Q6W5P4 2/20 0.52
ALDH1A1 P00352 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1973250 1.00 HTR2A (0.66) HTR2AHTR1DHTR1AHTR2CHTR1B
SCHEMBL10773237 0.89 HTR2A (0.61) HTR2AHTR1DHTR1AHTR2CHTR1B
SCHEMBL32669398 0.83 HTR1A (0.66) HTR2AHTR1DHTR1AHTR2CHTR1B
SCHEMBL25747785 0.80 HTR2C (0.60) HTR2AHTR1DHTR1AHTR2CHTR1B
SCHEMBL10770864 0.80 HTR1A (0.61) HTR2AHTR1DHTR1AHTR2CHTR1B
SCHEMBL10772090 0.80 HTR1A (0.61) HTR2AHTR1DHTR1AHTR2CHTR1B
SCHEMBL27077936 0.80 HTR2A (0.65) HTR2AHTR1DHTR1AHTR2CHTR1B
SCHEMBL30249043 0.80 HTR1D (1.00) HTR2AHTR1DHTR1AHTR2CHTR1B
SCHEMBL20970981 0.80 HTR1D (1.00) HTR2AHTR1DHTR1AHTR2CHTR1B
SCHEMBL32669266 0.77 MPO (0.59) HTR2AHTR1DHTR1AHTR2CHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240342126-A1 HALLUCINOGEN-FATTY ACID COMBINATION MINDSET PHARMA INC. (CA) 2024-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240342126-A1 HALLUCINOGEN-FATTY ACID COMBINATION FAAH, HTR5A, FAAH2 HTR2A 8/4885HTR1D 22/4885HTR1A 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.